GlaxoSmithKline (GSK) S.R.L.
GlaxoSmithKline S.R.L., commonly referred to as GSK, is a prominent global healthcare company headquartered in Romania (RO). Established in 2000, GSK has made significant strides in the pharmaceutical and consumer healthcare industries, focusing on innovative medicines, vaccines, and consumer health products. With a strong presence in Europe and other major operational regions, GSK is renowned for its commitment to research and development, leading to groundbreaking treatments in areas such as respiratory diseases, HIV, and vaccines. The company’s core offerings, including its unique portfolio of prescription medications and over-the-counter products, underscore its dedication to improving patient outcomes. GSK's market position is bolstered by its notable achievements in public health, making it a trusted name in the industry. Through continuous innovation and a patient-centric approach, GSK remains at the forefront of healthcare solutions.
DitchCarbon Score
How does GlaxoSmithKline (GSK) S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline (GSK) S.R.L.'s score of 56 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline (GSK) S.R.L.'s reported carbon emissions
GlaxoSmithKline (GSK) S.R.L., headquartered in Romania, currently does not have available carbon emissions data for the most recent year, nor specific reduction targets or initiatives documented. Without concrete figures or commitments, it is challenging to assess their current climate impact or progress towards sustainability goals. In the broader context of the pharmaceutical industry, companies are increasingly focusing on reducing their carbon footprints and committing to science-based targets. GSK, like many of its peers, is expected to align with global climate initiatives, although specific details regarding their commitments or strategies remain unspecified at this time. As the industry evolves, GSK may implement measures to enhance transparency and accountability in their environmental practices, contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline (GSK) S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
